Close Menu

It's not exactly uplifting, but this article from the Wall Street Journal reports on the fate of the pharmaceutical industry. (We'd say it places it somewhere between "embattled" and "dire.") While a number of blockbuster drugs are coming off patent, fewer and fewer drugs have gone on the market, and -- at least according to pharma execs -- FDA is getting increasingly picky about handing out approvals.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.